{"corpus_id":199000131,"paper_sha":"acb90e386e01a77a9ac5961a31eaabb733ffa284","doi":"10.1002/ajh.25595","arxiv_id":null,"pmid":31364186,"pmcid":null,"mag_id":2964876593,"dblp_id":null,"acl_id":null,"title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","year":2019,"publication_date":"2019-11-01","venue":"American journal of hematology/oncology","journal":{"name":"American Journal of Hematology","pages":"1266 - 1287","volume":"94"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't","Review"],"s2_fields_of_study":["Medicine"],"reference_count":219,"citation_count":438,"influential_citation_count":29,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Antineoplastic Combined Chemotherapy Protocols","mj":false,"qs":[{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D000971"},{"d":"B-Lymphocytes","mj":false,"qs":[{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D001402"},{"d":"Biomarkers, Tumor","mj":false,"ui":"D014408"},{"d":"Blood Cell Count","mj":false,"ui":"D001772"},{"d":"Chromosome Deletion","mj":false,"ui":"D002872"},{"d":"Combined Modality Therapy","mj":false,"ui":"D003131"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Forecasting","mj":false,"ui":"D005544"},{"d":"Hematopoietic Stem Cell Transplantation","mj":false,"ui":"D018380"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Immunophenotyping","mj":false,"ui":"D016130"},{"d":"Immunotherapy","mj":false,"ui":"D007167"},{"d":"Leukemia, Lymphocytic, Chronic, B-Cell","mj":true,"qs":[{"q":"diagnosis","mj":false,"ui":"Q000175"},{"q":"epidemiology","mj":false,"ui":"Q000453"},{"q":"genetics","mj":false,"ui":"Q000235"},{"q":"therapy","mj":false,"ui":"Q000628"}],"ui":"D015451"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Molecular Targeted Therapy","mj":false,"ui":"D058990"},{"d":"Mutation","mj":false,"ui":"D009154"},{"d":"Neoplasm Staging","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D009367"},{"d":"Prognosis","mj":false,"ui":"D011379"},{"d":"Risk Assessment","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D018570"}],"chemicals":[{"n":"Biomarkers, Tumor","ui":"D014408","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25595","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/acb90e386e01a77a9ac5961a31eaabb733ffa284","s2_open_access_license":null,"s2_open_access_status":"BRONZE","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Chronic lymphocytic leukemia (CLL) is the commonest leukemia in western countries. The disease typically occurs in elderly patients and has a highly variable clinical course. Leukemic transformation is initiated by specific genomic alterations that impair apoptosis of clonal B‐cells.","claims":[{"public_id":"cl_f9df9df03dabde20f5b1910ccfbc0674","status":"active","text":"Leukemic transformation in chronic lymphocytic leukemia is initiated by specific genomic alterations that impair apoptosis of clonal B-cells.","confidence":0.92,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_f9df9df03dabde20f5b1910ccfbc0674"}],"concepts":[{"public_id":"co_310f483e9899926530d162a3e3739a84","status":"active","name":"western countries","description":"The geographic setting where chronic lymphocytic leukemia is described as especially common.","types":["geographic setting"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_310f483e9899926530d162a3e3739a84"},{"public_id":"co_48e0384f538162176faf779660f083c3","status":"active","name":"leukemic transformation","description":"The process by which cells become leukemic in chronic lymphocytic leukemia.","types":["biological process"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_48e0384f538162176faf779660f083c3"},{"public_id":"co_55ae5afd432690834eae582c4d890502","status":"active","name":"clinical course","description":"The progression pattern of chronic lymphocytic leukemia over time in affected patients.","types":["disease characteristic"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_55ae5afd432690834eae582c4d890502"},{"public_id":"co_63532508a025d1bab44919f80e10279d","status":"active","name":"apoptosis of clonal B-cells","description":"Programmed cell death in the clonal B-cell population involved in chronic lymphocytic leukemia.","types":["cellular process"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_63532508a025d1bab44919f80e10279d"},{"public_id":"co_76d9e85985a5f2810389b7e2f82d2c43","status":"active","name":"specific genomic alterations","description":"Disease-associated changes in the genome implicated in initiating leukemic transformation.","types":["genetic factor"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_76d9e85985a5f2810389b7e2f82d2c43"},{"public_id":"co_8b4cc84c4f7e997921f89dbcfa06ac29","status":"active","name":"risk stratification","description":"The classification of chronic lymphocytic leukemia patients by expected disease risk.","types":["clinical assessment"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_8b4cc84c4f7e997921f89dbcfa06ac29"},{"public_id":"co_c0fba20ae8eeb819df01d094745af682","status":"active","name":"diagnosis","description":"The identification of chronic lymphocytic leukemia as a clinical condition.","types":["clinical process"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_c0fba20ae8eeb819df01d094745af682"},{"public_id":"co_c20a304e1c1fb00668f7bfcb3ac9e406","status":"active","name":"treatment","description":"Therapeutic management approaches for chronic lymphocytic leukemia.","types":["clinical intervention"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_c20a304e1c1fb00668f7bfcb3ac9e406"},{"public_id":"co_ea04131c2b9dc7a86949599800db2cb8","status":"active","name":"chronic lymphocytic leukemia","description":"A leukemia of clonal B-cells discussed as a disease with variable clinical behavior.","types":["disease"],"aliases":["CLL"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_ea04131c2b9dc7a86949599800db2cb8"},{"public_id":"co_fe092c4ce81783de255f8f7b77f9acff","status":"active","name":"elderly patients","description":"The patient population in which chronic lymphocytic leukemia typically occurs.","types":["patient population"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_fe092c4ce81783de255f8f7b77f9acff"}],"external_ids":{"DOI":"10.1002/ajh.25595","ArXiv":null,"PubMed":31364186,"PubMedCentral":null,"MAG":2964876593,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25595","landing_url":"https://www.semanticscholar.org/paper/acb90e386e01a77a9ac5961a31eaabb733ffa284","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":null,"status":"BRONZE","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631194,"paper_uid":"4fe9a809-ee58-4587-8621-0c4e2ebd3043","canonical_identity":{"paper_id":631194,"paper_uid":"4fe9a809-ee58-4587-8621-0c4e2ebd3043","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/199000131"}